Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations ; volume:7 ; number:1 ; day:23 ; month:12 ; year:2019 ; pages:1-17 ; date:12.2019
Acta Neuropathologica Communications ; 7, Heft 1 (23.12.2019), 1-17, 12.2019
- Urheber
-
Arrant, Andrew E.
Roth, Jonathan R.
Boyle, Nicholas R.
Kashyap, Shreya N.
Hoffmann, Madelyn Q.
Murchison, Charles F.
Ramos, Eliana Marisa
Nana, Alissa L.
Spina, Salvatore
Grinberg, Lea T.
Miller, Bruce L.
Seeley, William W.
Roberson, Erik D.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-019-0872-6
- URN
-
urn:nbn:de:101:1-2020032713485046701940
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Arrant, Andrew E.
- Roth, Jonathan R.
- Boyle, Nicholas R.
- Kashyap, Shreya N.
- Hoffmann, Madelyn Q.
- Murchison, Charles F.
- Ramos, Eliana Marisa
- Nana, Alissa L.
- Spina, Salvatore
- Grinberg, Lea T.
- Miller, Bruce L.
- Seeley, William W.
- Roberson, Erik D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice
Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia
Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations
Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results
Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion
Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations
Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice
Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia
Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations
Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results
Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion
Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations
Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice
Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia
Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations
Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results
Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion
Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations